Preventing Infections in Higher-Risk Myelodysplastic Syndrome Patients Treated with Hypomethylation Agents
Department of Hematology and Bone Marrow Transplantation; Rambam Health Care Campus. Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
Citation: EMJ Hema. 2013;1:58-63.
Read this article in EMJ Hematology 2013: http://viewer.zmags.com/publication/f8ad81bc#/f8ad81bc/59
Also available for download: http://emjreviews.com/therapeutic-area/hematology/preventing-infections-higher-risk-myelodysplastic-syndrome-patients-treated-hypomethylation-agents/
Year of Production: